|
04-30-2010, 06:17 AM
|
|||
|
|||
Dendreons Provenge Approval Sparks New Era for Cancer Vaccines
April 30 (Bloomberg) -- Dendreon Corp. won approval for its only product, the prostate cancer vaccine Provenge, concluding a three-year battle with U.S. regulators to introduce the first therapy to train the bodys immune system to destroy tumors.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Provenge Approval a Boon for Other Cancer Vaccines, Report Says | cancerfr | Colon and Rectal Cancer | 0 | 09-10-2010 03:47 AM |
| Genital wart decline sparks call for men's vaccine | cancerfr | Vulvar Cancer | 0 | 07-06-2010 07:49 AM |
| Provenge Nod Bodes Well, but No Free Pass for Cancer Vaccines | cancerfr | Bladder Cancer | 0 | 05-03-2010 06:10 PM |
| Illness sparks better health campaign | cancerfr | Adrenocortical Carcinoma | 0 | 04-26-2010 02:19 PM |
Linear Mode
